Zinc (Zn) cations came under focus as a possible antidiabetic agent in 1980, when ZnCl2 was reported to stimulate lipogenesis in rat adipocytes in a manner similar to the action of insulin [10], aiding both types of diabetes treatment under high doses of ZnCl2 [11,12]. Here, INS is linked to diabetes mellitus.